Skip to main content
Figure 1 | BMC Medicine

Figure 1

From: Next generation sequencing and tumor mutation profiling: are we ready for routine use in the oncology clinic?

Figure 1

Debu Tripathy, MD is Professor of Medicine and Co-Leader of the Women's Cancer Program at University of Southern California/Norris Comprehensive Cancer Center and holds the Priscilla and Art Ulene Chair in Women’s Cancer. His area of clinical research interest is novel therapeutics in breast cancer, specifically, growth factor receptor pathway targeting as well as biomarkers that predict sensitivity and resistance. He is also part of a trans-disciplinary breast specialty team dedicated to patient-centered and personalized approaches to care, with an emphasis on translational clinical trials.

Back to article page